Impact of cystic fibrosis disease on archaea and bacteria composition of gut microbiota-Reference-Cited by-同舟云学术

Impact of cystic fibrosis disease on archaea and bacteria composition of gut microbiota

Published:2016-11-02 Issue:2 Volume:93 Page:fiw230
ISSN:1574-6941
Container-title:FEMS Microbiology Ecology
language:en
Short-container-title:FEMS Microbiology Ecology

Author:

Miragoli Francesco,Federici Sara,Ferrari Susanna,Minuti Andrea,Rebecchi Annalisa,Bruzzese Eugenia,Buccigrossi Vittoria,Guarino Alfredo,Callegari Maria Luisa

Publisher

Oxford University Press (OUP)

Subject

Applied Microbiology and Biotechnology,Ecology,Microbiology

Link

http://academic.oup.com/femsec/article-pdf/93/2/fiw230/16737473/fiw230.pdf

Reference76 articles.

1. Distal gut microbiota of adolescent children is different from that of adults

2. Phylogenetic Relationships of Butyrate-Producing Bacteria from the Human Gut

3. Two routes of metabolic cross-feeding between;Belenguer;Society,2006

4. Diversity of H 2 /CO 2 -Utilizing Acetogenic Bacteria from Fecesof Non-Methane-Producing Humans

5. Disrupted Intestinal Microbiota and Intestinal Inflammation in Children with Cystic Fibrosis and Its Restoration with Lactobacillus GG: A Randomised Clinical Trial

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The gastrointestinal microbiome, small bowel bacterial overgrowth, and microbiome modulators in cystic fibrosis;Pediatric Pulmonology;2024-08-06

2. The effect of Lactobacillus reuteri on pulmonary function test and growth of cystic fibrosis patients;Journal of the Science of Food and Agriculture;2024-07-10

3. The Archaea domain: Exploring historical and contemporary perspectives with in silico primer coverage analysis for future research in Dentistry;Archives of Oral Biology;2024-05

4. Impact of extended Elexacaftor/Tezacaftor/Ivacaftor therapy on the gut microbiome in cystic fibrosis;Journal of Cystic Fibrosis;2024-05

5. Longitudinal profiling of the intestinal microbiome in children with cystic fibrosis treated with elexacaftor-tezacaftor-ivacaftor;mBio;2024-02-14